Phaseline

Targets › DTPA

DTPA: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Other; next expected readout Jan 2028.

Open in Phaseline: the race on DTPA, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Northwestern UniversityGadavist 2Ml Solution for Injection
gadolinium-based contrast agent (gadopentetate dimeglumine)
DTPAPhase 4Image, BodyJan 2028

Conditions

Image, Body (1)

Modalities

small molecule (1)

Companies

Northwestern University (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.